OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

$38.2M

Market Cap • 1/10/2025

2007

(18 years)
Founded

2022

(3 years ago)
IPO

NASDAQ

Listing Exchange
Flag of GB

London

Headquarters